We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+8.51%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.52B
AUM Growth
+$1.2B
(+19%)
Cap. Flow
+$726M
Cap. Flow
% of AUM
9.65%
Top 10 Holdings %
Top 10 Hldgs %
19.11%
Holding
866
New
79
Increased
318
Reduced
279
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$75M |
| 2 |
Biogen
BIIB
|
+$70.7M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$60.1M |
| 4 |
Merck
MRK
|
+$54.6M |
| 5 |
Gilead Sciences
GILD
|
+$33.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$19.1M |
| 2 |
IRBT
iRobot
IRBT
|
+$15.5M |
| 3 |
Quest Diagnostics
DGX
|
+$15.4M |
| 4 |
Colgate-Palmolive
CL
|
+$14.8M |
| 5 |
Philip Morris
PM
|
+$12.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.26% |
| 2 | Technology | 16.05% |
| 3 | Financials | 11.26% |
| 4 | Consumer Discretionary | 7.98% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
General Mills
GIS
$19.2B
| $7.1M | 0.09% |
165,493
+122,138
| +282% | +$5.53M |
|
|
WBC
252
DELISTED
WABCO HOLDINGS INC.
WBC
| $7.04M | 0.09% |
59,728
| – | – |
|
253
AnaptysBio
ANAB
$1.64B
| $6.98M | 0.09% |
70,000
+35,900
| +105% | +$2.98M |
|
254
iShares US Real Estate ETF
IYR
$4.74B
| $6.96M | 0.09% |
86,996
+302
| +0.3% | +$24.6K |
|
255
United Rentals
URI
$70.1B
| $6.94M | 0.09% |
42,424
+35,342
| +499% | +$5.5M |
|
256
Newmont
NEM
$98.6B
| $6.94M | 0.09% |
229,674
+73,180
| +47% | +$2.48M |
|
257
Host Hotels & Resorts
HST
$17B
| $6.9M | 0.09% |
326,808
-157,615
| -33% | -$3.33M |
|
|
ORIG
258
DELISTED
Ocean Rig UDW Inc. Class A Common Shares
ORIG
| $6.83M | 0.09% |
+197,194
| New | +$5.69M |
|
259
Fidelity National Information Services
FIS
$22.1B
| $6.78M | 0.09% |
62,154
+37,656
| +154% | +$4.06M |
|
260
EOG Resources
EOG
$76.5B
| $6.73M | 0.09% |
52,772
-7,644
| -13% | -$929K |
|
|
KTWO
261
DELISTED
K2M Group Holdings, Inc
KTWO
| $6.71M | 0.09% |
245,000
+110,000
| +81% | +$2.58M |
|
262
iShares MSCI Canada ETF
EWC
$6.13B
| $6.7M | 0.09% |
232,666
| – | – |
|
|
RHT
263
DELISTED
Red Hat Inc
RHT
| $6.63M | 0.09% |
48,629
+34,819
| +252% | +$4.98M |
|
|
GAP
264
The Gap Inc
GAP
$6.89B
| $6.57M | 0.09% |
227,625
+137,550
| +153% | +$4.12M |
|
|
ARQL
265
DELISTED
Arqule Inc
ARQL
| $6.52M | 0.09% |
1,152,727
+587,727
| +104% | +$3.34M |
|
|
GPT
266
DELISTED
Gramercy Property Trust
GPT
| $6.44M | 0.09% |
+234,714
| New | +$6.42M |
|
267
Exelixis
EXEL
$14.2B
| $6.42M | 0.09% |
362,500
+103,000
| +40% | +$2.01M |
|
|
FOLD
268
DELISTED
Amicus Therapeutics
FOLD
| $6.42M | 0.09% |
531,000
+70,000
| +15% | +$979K |
|
269
Zillow
Z
$7.21B
| $6.42M | 0.09% |
144,994
+77,936
| +116% | +$4.06M |
|
270
Zimmer Biomet
ZBH
$18B
| $6.41M | 0.09% |
50,242
-70,245
| -58% | -$8.35M |
|
271
Kura Oncology
KURA
$950M
| $6.41M | 0.09% |
366,000
-16,000
| -4% | -$307K |
|
|
CLVS
272
DELISTED
Clovis Oncology, Inc.
CLVS
| $6.38M | 0.08% |
217,100
+21,100
| +11% | +$817K |
|
|
GWPH
273
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $6.33M | 0.08% |
36,620
+10,700
| +41% | +$1.54M |
|
|
ESRX
274
DELISTED
Express Scripts Holding Company
ESRX
| $6.32M | 0.08% |
66,485
-7,077
| -10% | -$603K |
|
275
Veeco
VECO
$3.05B
| $6.31M | 0.08% |
615,443
+207,796
| +51% | +$2.6M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q3 2018 Portfolio in Review
As of Q3 2018, Candriam SCA held 866 positions worth $7.52B, up 19% from $6.32B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Candriam SCA deployed $726M of net new capital in Q3 2018, opening 79 new positions and adding to 318 existing holdings. Its largest new stake was Varonis Systems: 541,092 shares worth $13.2M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 25% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Advanced Micro Devices, an estimated $19.1M trimmed.
- Candriam SCA's largest Q3 2018 buy was Varonis Systems: 541,092 shares worth $13.2M.
- Candriam SCA added most to Amgen in Q3 2018, an estimated $75M increase.
- Candriam SCA's biggest Q3 2018 reduction was Advanced Micro Devices, cutting an estimated $19.1M.
- Candriam SCA fully exited iRobot in Q3 2018, selling an estimated $15.5M.
- Candriam SCA's ten largest holdings make up 19% of its $7.52B portfolio in Q3 2018.
- Candriam SCA opened 79 new positions and closed 56 in Q3 2018.
- Candriam SCA's portfolio value rose 19% quarter-over-quarter to $7.52B.
Based on Candriam SCA's 13F filing for Q3 2018, filed 7 Nov 2018.